KalVista Pharmaceuticals
KALV
KALV
160 hedge funds and large institutions have $1.08B invested in KalVista Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 53 increasing their positions, 48 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
16.38% more ownership
Funds ownership: 116.05% → 132.43% (+16%)
10% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 48
10% more funds holding
Funds holding: 145 → 160 (+15)
Holders
160
Holding in Top 10
5
Calls
$6.69M
Puts
$236K
Top Buyers
| 1 | +$30.2M | |
| 2 | +$16M | |
| 3 | +$15.1M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$14.1M |
| 5 |
Millennium Management
New York
|
+$10.6M |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$8.33M | |
| 3 | -$6.2M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$4.89M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$4.52M |
